Results 171 to 180 of about 6,036 (190)

Benefits From Small Molecule Administration as Compared With Abciximab Among Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Angioplasty

Journal of the American College of Cardiology, 2009
Giuseppe De Luca, Paolo Marino, Ettore Cassetti   +2 more
exaly  

Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI

International Journal of Cardiology, 2005
Giuseppe Biondi-Zoccai, Carlo Trani, Giampaolo Niccoli   +2 more
exaly  

Different effects of abciximab and cytochalasin D on clot strength in thrombelastography

Journal of Thrombosis and Haemostasis, 2004
W Toller, H Metzler, T Lang
exaly  

Abciximab

Reactions Weekly, 2010
openaire   +1 more source

Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug

Journal of Thrombosis and Haemostasis, 2004
B R Curtis, R H Aster
exaly  

Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.

Journal of the American College of Cardiology, 2010
Ralf Zahn, Jean-Marc Lablanche, Hubertus Heuer   +2 more
exaly  

Cryo-Electron Microscopy Structure of the αIIbβ3-Abciximab Complex

Arteriosclerosis, Thrombosis, and Vascular Biology, 2020
Davide Provasi, Marta Filizola, Aleksandar Spasic   +2 more
exaly  

Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).

Journal of the American College of Cardiology, 2010
Axel Åkerblom, Jonas Oldgren, Stefan James   +2 more
exaly  

Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial

Lancet, The, 2002
Markus Schwaiger, Stephan G Nekolla, Melchior Seyfarth   +2 more
exaly  

Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy

Catheterization and Cardiovascular Interventions, 2001

exaly